✦ LIBER ✦

TCT-267 Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-Up of the PEPCAD China ISR Trial

✍ Scribed by Zhao, Yelin; Xu, Bo; Ge, Junbo; Yang, Yuejin; Wang, Jian'an; Chen, Shao Liang; Liu, Bin; Chen, Fang; Gao, Run-Lin

Book ID: 126933149
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 70 KB
Volume: 64
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2014.07.311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCTAP A-002 Paclitaxel-coated Balloon Ve

TCTAP A-002 Paclitaxel-coated Balloon Versus Paclitaxel-eluting Stent for the Treatment of Diffuse DES In-stent Restenotic Lesions: A Substudy of PEPCAD China ISR Trial

✍ Zhao, Ye-lin; Xu, Bo; Qian, Jie; Wang, Jian-an; Chen, Shao-liang; Yang, Yue-jing 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 146 KB

TCT-56 PEPCAD China ISR: A Prospective,

TCT-56 PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis - 9-Month Angiographic and 12-Month Clinical Results

✍ Xu, Bo; Gao, Run-Lin; Wang, Jian'an; Yang, Yuejin; Chen, Shao Liang; Liu, Bin; C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 158 KB

TCT-466 Paclitaxel-coated Balloon Versus

TCT-466 Paclitaxel-coated Balloon Versus Drug-eluting Stent for the Treatment of In-stent Restenosis in Patients with Renal Failure on Hemodialysis

✍ Hyodo, Yusuke; Fuku, Yasushi; Goto, Tsuyoshi; Habara, Seiji; Hasegawa, Daiji; Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Elutax paclitaxel-eluting balloon follow

Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: A randomized trial

✍ Liistro, Francesco; Porto, Italo; Angioli, Paolo; Grotti, Simone; Ducci, Kenneth 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 604 KB

TCT-404: Late Safety and Efficacy of a Z

TCT-404: Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB